Published in J Cereb Blood Flow Metab on May 01, 1996
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest (2003) 3.41
Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience (2008) 2.55
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci (2002) 2.21
Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat. Hypertension (2008) 1.98
Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke (2004) 1.81
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci (2006) 1.69
Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology. Stroke (2011) 1.53
Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery. PLoS One (2015) 1.45
White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke (2010) 1.33
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke (2009) 1.30
Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets (2008) 1.24
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab (2009) 1.23
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging (2008) 1.20
Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J (2002) 1.15
Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res (2010) 1.14
Minocycline development for acute ischemic stroke. Transl Stroke Res (2011) 1.12
Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci (2005) 1.11
Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res (2009) 1.10
uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPK. Brain Res (2008) 1.09
Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration. Invest Ophthalmol Vis Sci (2008) 1.04
Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol (2008) 1.01
Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res (2013) 0.97
Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci (2012) 0.96
MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J (2008) 0.95
Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Transl Stroke Res (2010) 0.94
Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models. Acta Pharmacol Sin (2011) 0.93
Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury. J Cereb Blood Flow Metab (2010) 0.92
A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury. Cell Death Dis (2014) 0.89
Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke. J Cereb Blood Flow Metab (2010) 0.88
Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients. Stroke Res Treat (2011) 0.87
Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci (2012) 0.87
Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation. Glia (2009) 0.86
Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Metab Brain Dis (2014) 0.84
Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Hum Genet (2006) 0.83
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke. Mol Brain (2013) 0.82
Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag (2013) 0.82
Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism. Neuroscience (2011) 0.81
The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia. Graefes Arch Clin Exp Ophthalmol (2006) 0.80
Pharmaco-proteomics opportunities for individualizing neurovascular treatment. Neurol Res (2013) 0.80
Hemostasis and alterations of the central nervous system. Semin Thromb Hemost (2013) 0.79
Aging and the neurovascular unit. Ann N Y Acad Sci (2012) 0.79
Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. Cardiovasc Hematol Agents Med Chem (2007) 0.79
Amelioration of cold injury-induced cortical brain edema formation by selective endothelin ETB receptor antagonists in mice. PLoS One (2014) 0.78
Application of proteomics to cerebrovascular disease. Electrophoresis (2012) 0.77
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. J Cereb Blood Flow Metab (2016) 0.77
Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke. Neurol Sci (2012) 0.77
Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat (2013) 0.76
PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation. Stroke (2015) 0.76
Anti-tissue plasminogen activator (tPA) as an effective therapy of neonatal hypoxia-ischemia with and without inflammation. CNS Neurosci Ther (2014) 0.76
THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION. Drug Discov Today Dis Models (2011) 0.76
Matrix metalloproteinase-9 and -2 expression in the olfactory bulb following methyl bromide gas exposure. Chem Senses (2010) 0.76
Optimal level activity of matrix metalloproteinases is critical for adult visual plasticity in the healthy and stroke-affected brain. Elife (2015) 0.76
Matrix metalloproteinase-9 is associated with acute inflammation after olfactory injury. Neuroreport (2011) 0.75
Preventive Ceftriaxone in Patients with Stroke Treated with Intravenous Thrombolysis: Post Hoc Analysis of the Preventive Antibiotics in Stroke Study. Cerebrovasc Dis (2016) 0.75
Blockade of Apoptosis Signal-Regulating Kinase 1 Attenuates Matrix Metalloproteinase 9 Activity in Brain Endothelial Cells and the Subsequent Apoptosis in Neurons after Ischemic Injury. Front Cell Neurosci (2016) 0.75
Computer modeling of ischemic stroke. Scholarpedia J (2016) 0.75
Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke. Hypertens Res (2016) 0.75
Hydrogen improves neurological function through attenuation of blood-brain barrier disruption in spontaneously hypertensive stroke-prone rats. BMC Neurosci (2015) 0.75
Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxid Med Cell Longev (2016) 0.75
Relationships between free radical levels during carotid endarterectomy and markers of arteriosclerotic disease. Int J Med Sci (2007) 0.75
The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction. Int J Clin Exp Med (2015) 0.75
Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model. PLoS One (2016) 0.75
Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet (1996) 3.80
Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther (1992) 1.72
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci U S A (1987) 1.48
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J Trauma (1993) 1.42
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology (1997) 1.28
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology (1996) 1.24
Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. Stroke (1987) 1.12
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke (1999) 0.98
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98
Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol (1987) 0.98
The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus. Arch Virol (1989) 0.97
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res (1991) 0.97
Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke (1988) 0.95
Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett (2011) 0.93
Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol (1992) 0.93
Leukotrienes and the cardiovascular system. Prostaglandins (1984) 0.92
Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1992) 0.92
An improved clinically relevant sepsis model in the conscious rat. Crit Care Med (2000) 0.92
Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and omega-conotoxin-insensitive pathways. Neuroscience (1989) 0.92
Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli. Br J Pharmacol (1971) 0.92
Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2. Brain Res (1982) 0.91
Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats. J Cereb Blood Flow Metab (1994) 0.91
Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology (1983) 0.90
Effect of platelet-activating factor on coronary circulation of the domestic pig. Am J Physiol (1984) 0.90
Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol (1989) 0.90
Vasopressin: an essential pressor factor for blood pressure recovery following hemorrhage. Peptides (1982) 0.90
Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat. J Pharmacol Exp Ther (1988) 0.89
Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke (1987) 0.89
Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. Circ Shock (1990) 0.88
Platelet-activating factor in stroke and brain injury. Ann Neurol (1991) 0.88
Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia. Stroke (1992) 0.88
Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. J Lipid Mediat (1992) 0.87
Validation of laser-Doppler flowmetry in measurement of spinal cord blood flow. Am J Physiol (1989) 0.86
Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors. Br J Pharmacol (1983) 0.86
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. J Pharmacol Exp Ther (1993) 0.86
The opioid peptides. A role in hypertension? Hypertension (1987) 0.86
mu Receptors and opioid cardiovascular effects in the NTS of rat. Peptides (1983) 0.86
Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia. Acta Neuropathol (1990) 0.86
Identification of endothelin receptors in various regions of rat brain. Neuropeptides (1990) 0.86
Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun (1985) 0.85
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours. Br J Cancer (2011) 0.85
Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability. Oncogene (2012) 0.85
Postischemic production of eicosanoids in gerbil brain. Stroke (1987) 0.85
Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. Am J Cardiol (1983) 0.85
Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res (1992) 0.85
Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. Life Sci (1983) 0.85
Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther (1990) 0.85
Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. Prostaglandins (1987) 0.85
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists. J Med Chem (1996) 0.84
Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol (1996) 0.84
Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1994) 0.84
Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. Eur J Pharmacol (1992) 0.84
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke (1990) 0.84
Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy. Herz (2010) 0.84
Effect of endothelin on cortical microvascular perfusion in rats. Stroke (1990) 0.84
Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury. Brain Res (1981) 0.83
Torsional constant of 27-mer DNA oligomers of different sequences. Biophys Chem (2001) 0.83
Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. J Pharmacol Exp Ther (1990) 0.83
Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress. J Med Virol (1992) 0.83
Lymph node IL-18 expression in adult-onset Still's disease. Ann Rheum Dis (2009) 0.83
Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury. Circ Res (1996) 0.82
Endothelin and heart failure. Heart Fail Rev (2001) 0.82
Identification and complete genome analysis of a virus variant or putative new foveavirus associated with apple green crinkle disease. Arch Virol (2013) 0.82
Methionine and leucine enkephalin in rat neurohypophysis: different responses to osmotic stimuli and T2 toxin. Science (1985) 0.82
Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma (1993) 0.82
mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. Am J Physiol (1987) 0.82
Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia. J Pharm Pharmacol (1981) 0.81
CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. Peptides (1992) 0.81
Aspiration-induced lung injury: role of complement. Crit Care Med (1995) 0.81
Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. J Appl Physiol (1985) (1997) 0.81
Monoclonal antibodies against the presynaptic calcium channel antagonist omega-conotoxin GVI A from cone snail poison. FEBS Lett (1990) 0.81
Autonomic pharmacology of leukotrienes. J Auton Pharmacol (1985) 0.81
Homologous desensitization of calcitonin gene-related peptide response in rat glomerular mesangial cells in culture. Mol Cell Biochem (1992) 0.81
Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Clin Exp Rheumatol (2008) 0.81
Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. J Pharmacol Exp Ther (1984) 0.81
Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res (1991) 0.81
Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther (1994) 0.81
Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res (1988) 0.81
Effects of FPL-55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart. Eur J Pharmacol (1983) 0.81
Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TGF-beta 1) production by rat aortic smooth muscle cells. Biochem Biophys Res Commun (1994) 0.81
Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus. Neuropharmacology (1984) 0.81
Leukotrienes in health and disease. FASEB J (1987) 0.80
Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. Mol Pharmacol (1992) 0.80
The prevalence of the acétylcholine reactivity in cotton mill workers. Rev Inst Hyg Mines (Hasselt) (1973) 0.80
TRH: cardiovascular and sympathetic modulation in brain nuclei of the rat. Peptides (1984) 0.80
Effect of naloxone on the cardiovascular and sympathetic response to hypovolemic hypotension in the rat. Eur J Pharmacol (1981) 0.80
Bombesin and substance P modulate peripheral sympathetic and cardiovascular activity. Peptides (1985) 0.80
Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen. Neoplasma (2006) 0.80
Cardiovascular, sympathetic, and renin-angiotensin system responses to hemorrhage in vasopressin-deficient rats. Endocrinology (1982) 0.80
Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat. Am J Physiol (1986) 0.80
Delta versus mu receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats. Regul Pept (1982) 0.80
Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. J Neurochem (1994) 0.80
Relationships between cell killing, mutation induction and DNA damage in X-irradiated V79 cells: the influence of oxygen and DMSO. Int J Radiat Biol (1991) 0.80
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke (1992) 0.80
Alteration in opiate receptors binding after hemorrhagic shock. Eur J Pharmacol (1984) 0.80